Search results for " Oncogenic"

showing 4 items of 4 documents

Impact of microRNAs in Resistance to Chemotherapy and Novel Targeted Agents in Non-Small Cell Lung Cancer

2014

Despite recent advances in understanding the cancer signaling pathways and in developing new therapeutic strategies, non-small cell lung cancer (NSCLC) shows grim prognosis and high incidence of recurrence. Insufficient dis- ruption of oncogenic signaling and drug resistance are the most common causes of tumor recurrence. Drug resistance, in- trinsic or acquired, represents a main obstacle in NSCLC therapeutics by limiting the efficacy both of conventional che- motherapeutic compounds and new targeted agents. Therefore, novel and more innovative approaches are required for treatment of this tumor. MicroRNAs (miRNAs) are a family of small non-coding RNAs that regulate gene expression by sequ…

DrugSettore MED/06 - Oncologia Medicamedia_common.quotation_subjectGene regulatory networkPharmaceutical ScienceAntineoplastic AgentsDrug resistanceBiologyBioinformaticsCarcinoma Non-Small-Cell LungmicroRNAmedicineAnimalsHumansLung cancerBiologymedia_commonPharmacology. TherapyCell cyclemedicine.diseaseMicroRNAsChemistryDrug Resistance NeoplasmChemotherapy lung cancer microRNA oncogenic pathways resistance targeted agentsCancer cellSignal transductionSettore MED/46 - Scienze Tecniche Di Medicina Di LaboratorioBiotechnology
researchProduct

DOUBLE DEMONSTRATION OF ONCOGENIC HIGH RISK HUMAN PAPILLOMA VIRUS DNA AND HPV-E7 PROTEIN IN ORAL CANCERS

2011

Oncogenic HPVs are necessarily involved in cervical cancer but their role in oral carcinogenesis is debated. To detect HPV in oral cancer, 38 cases of formalin fixed-paraffin embedded OSCC were studied by both DNA genotyping (MY09/11 L1 consensus primers in combination with GP5-GP6 primer pair followed by sequencing) and immunohistochemistry (monoclonal Abs against capsid protein and HPV-E7 protein, K1H8 DAKO and clone 8C9 INVITROGEN, respectively). HPV-16 tonsil cancer was used as positive control. The overall prevalence of HPV infection in OSCCs was 10.5%. Amplification of DNA samples showed single HPV DNA infection in 3 cases (HPV16; HPV53; HPV70) and double infection in one case of chee…

AdultMaleHPVPapillomavirus E7 ProteinsImmunologyBiologymedicine.disease_causeVirusoral carcinogenesisSettore MED/28 - Malattie Odontostomatologicheoncogenic proteinsmedicineImmunology and AllergyHumansGenotypingPapillomaviridaeAgedNeoplasm StagingPharmacologyCervical cancerAged 80 and overE-7Papillomavirus InfectionsHPV infectionCancervirus diseasesMiddle Agedmedicine.diseaseHPV oral cancerVirologyfemale genital diseases and pregnancy complicationsstomatognathic diseasesCancer cellDNA ViralCarcinoma Squamous CellE-7; HPV; oncogenic proteins; oral carcinogenesis; OSCC;FemaleMouth NeoplasmsOSCCPrimer (molecular biology)Carcinogenesis
researchProduct

The effects of HPV infection on semen: first results from a new approach.

2017

Study question: The effect of HPV infection on semen characteristics was investigated using a new method that allow to evaluate virus localization in the different semen components. Summary answer: Our data indicate a correlation between HPV infection of exfoliated epithelial cells (from spermatic ducts and accessory glands) and reduction of sperm cell motility. What is known already: HPVs are agents of the most common sexually transmitted diseases. Both in men and in women, HPVs cause a variety of clinical symptoms ranging from warts to cancer. It has been shown (IARC, 2009) that infection with 12 oncogenic HPVs is the major cause of development of cervical cancer in women and it is also r…

Settore MED/07 - Microbiologia E Microbiologia ClinicaSexually transmitted diseases oncogenic viruses HPV infection semen parameters male infertilitySettore BIO/11 - Biologia MolecolareSettore BIO/06 - Anatomia Comparata E Citologia
researchProduct

Demonstration of antibodies to the surface (anti-p41) and core proteins (anti-p24) of the human immunodeficiency virus (HIV) in individuals positive …

1987

Diagnosis of infection with the human immunodeficiency virus (HIV) relies on the demonstration of antibody to this virus. Occasionally, the combined analysis of sera using ELISA and western blot reveals false-positive results. We have compared a newly developed test to detect antibodies to the core (anti-p24) and surface (anti-p41) proteins of HIV with the established tests described above. Anti-p24 and anti-p41 were negative in three individuals positive for anti-HIV by ELISA and immunoblot; they had a low risk to acquire HIV infection and were clinically and immunologically normal and suspected false positive previously. In 62 individuals at risk, anti-p41 was always positive while anti-p…

MaleRiskRetroviridae Proteins OncogenicHuman immunodeficiency virus (HIV)Retroviridae ProteinsEnzyme-Linked Immunosorbent AssayHIV Antibodiesmedicine.disease_causeAntibodies ViralVirusAcquired immunodeficiency syndrome (AIDS)Western blotViral Envelope ProteinsAntibody SpecificityDrug DiscoverymedicineHumansGenetics (clinical)Acquired Immunodeficiency Syndromebiologymedicine.diagnostic_testAnti hivvirus diseasesHIVCore proteinGeneral Medicinemedicine.diseaseVirologyHIV Envelope Protein gp41Immunologybiology.proteinMolecular MedicineFemaleAntibodyKlinische Wochenschrift
researchProduct